Seeking Alpha
 

Zimmer Biomet Holdings, Inc. (ZBH)

- NYSE
  • Thu, Jul. 30, 7:33 AM
    • Zimmer Biomet (NYSE:ZBH): Q2 EPS of $1.59 beats by $0.04.
    • Revenue of $1.17B (-0.8% Y/Y) misses by $20M.
    • Press Release
    | Thu, Jul. 30, 7:33 AM | Comment!
  • Thu, Apr. 30, 9:19 AM
    • Zimmer Holdings (NYSE:ZMH) Q1 results ($M): Total Revenues: 1,134.4 (-2.3%); Reconstructive: 851.7 (-2.3%); Dental: 55.8 (-8.5%); Trauma: 79.4 (-0.4%); Spine: 49.5 (+2.5%); Surgical & Other: 98.0 (-2.4%).
    • Net Income: 177.1 (-20.0%); EPS: 1.02 (-20.9%); CF Ops: 91.5 (-51.5%).
    • 2015 Guidance: Non-GAAP EPS: $6.30 - 6.40 from $6.50 - 6.60.
    | Thu, Apr. 30, 9:19 AM | Comment!
  • Thu, Apr. 30, 7:34 AM
    • Zimmer Holdings (NYSE:ZMH): Q1 EPS of $1.58 beats by $0.07.
    • Revenue of $1.13B (-2.6% Y/Y) misses by $20M.
    • Press Release
    | Thu, Apr. 30, 7:34 AM | Comment!
  • Thu, Jan. 29, 8:23 AM
    • Zimmer Holdings (NYSE:ZMH) Q4 results ($M): Total Revenues: 1,222.9 (-1.4%); Americas: 677.9 (-2.1%); Europe: 337.2 (-1.6%); Asia Pacific: 207.8 (+0.9%); Reconstructive: 910.6 (-1.9%); Dental: 66.8 (+5.9%); Trauma: 80.4 (-0.7%); Spine: 55.7 (+6.3%); Surgical & Other: 109.4 (-5.6%).
    • Reconstructive: Knees: 518.6 (-0.9%); Hips: 338.1 (-4.2%); Extremities: 53.9 (+3.9%).
    • COGS: 312.9 (-8.2%); R&D Expense: 46.6 (+0.4%); SG&A Expense: 458.9 (-3.8%); Net Income: 156.5 (-33.5%); EPS: .91 (-33.1%); CF Ops: 354.2 (+18.0%); Quick Assets: 1,695.8 (-6.2%).
    • Gross Profit: 910.0 (+1.1%); COGS: 25.6% (-6.9%); Gross Margin: 74.4% (+2.6%); Operating Earnings: 404.5 (+7.4%); Operating Earnings Yield: 33.1% (+9.0%); Net Earnings Yield: 12.8% (-32.5%).
    • Q1 Guidance: Revenue Growth: 1.5 - 2.5%; Non-GAAP EPS: $1.58 - 1.60; GAAP EPS: $1.12 - 1.14.
    | Thu, Jan. 29, 8:23 AM | Comment!
  • Thu, Jan. 29, 7:14 AM
    • Zimmer Holdings (NYSE:ZMH): Q4 EPS of $1.71 in-line.
    • Revenue of $1.22B (-1.6% Y/Y) misses by $20M.
    • Press Release
    | Thu, Jan. 29, 7:14 AM | Comment!
  • Fri, Jan. 16, 12:18 PM
    • Zimmer Holdings (ZMH +1%) will report Q4 and full-year results on January 29 before the open. The conference call will begin at 8:00 am ET.
    • Consensus views for revenue for Q4 and 2014 are $1.25B and $4.70B, respectively.
    | Fri, Jan. 16, 12:18 PM | Comment!
  • Oct. 23, 2014, 8:05 AM
    • Zimmer Holdings (NYSE:ZMH) Q3 results ($M): Revenues: 1,106.0 (+3.0%); Gross Profit: 807.7 (+8.3%); R&D Expense: 46.1 (-6.7%); SG&A Expense: 443.5 (+9.9%); Operating Income: 251.2 (+18.7%); Net Income: 165.5 (+7.2%); EPS: 0.96 (+6.7%); Quick Assets: 1,747.1 (-3.3%); CF Ops: 255.7.
    • Revenue By Geographic Segment: Americas: 637.9 (+0.8%); Europe: 270.7 (+6.2%); Asia Pacific: 197.4 (+5.9%).
    • Revenue By Product Category: Reconstructive: 823.8 (+4.5%), Knees: 461.4 (+6.2%), Hips: 315.6 (+2.4%); Extremities: 46.8 (+2.9%); Dental: 53.9 (-2.2%); Trauma: 77.8 (-0.9%); Spine: 51.0 (+6.3%); Surgical & Other: 99.5 (-4.7%).
    • 2014 Guidance: Revenue growth: ~2.25% from 2.0 - 3.0%; EPS: ~$4.65 from $4.65 - 4.75; non-GAAP EPS: ~$6.05 from $6.00 - 6.10.
    | Oct. 23, 2014, 8:05 AM | Comment!
  • Oct. 23, 2014, 7:33 AM
    • Zimmer Holdings (NYSE:ZMH): Q3 EPS of $1.35 beats by $0.05.
    • Revenue of $1.11B (+3.7% Y/Y) beats by $10M.
    • Press Release
    | Oct. 23, 2014, 7:33 AM | Comment!
  • Oct. 19, 2014, 6:37 PM
    • Zimmer Holdings (NYSE:ZMH) will report Q3 results on October 23 before the open. The conference call will begin at 8:00 am ET.
    • Consensus view is EPS of $1.30 on revenues of $1.1B.
    | Oct. 19, 2014, 6:37 PM | Comment!
  • Jul. 24, 2014, 1:04 PM
    • Zimmer Holdings (ZMH -3.5%) Q2 results: Net Sales: $1,182.9M (+1.1%), Reconstructive: $890.4M (+2.6%), Dental: $61.1M (-0.5%), Trauma: $78.8M (+6.3%), Spine: $52.2M (-3.7%), Surgical & Other: $100.4M (-10.2%); COGS: $333.2 (+3.0%); Gross Profit: $849.7M (+0.4%); R&D Expense: $48.1M (-12.4%); SG&A Expense: $455.8M (0.5%); Operating Income: $259.3M (+23.2%); Net Income: $176.1M (+16.1%); EPS: $1.03 (+15.7%); Quick Assets: $1,698.0M (-6.1%); CF Ops (1H): $442.9M (+19.6%).
    • 2014 Guidance: revenue growth: 2.0 - 3.0% from 3.0 - 5.0%; diluted GAAP EPS: $4.65 - 4.75 from $4.90 - 5.10; diluted non-GAAP EPS: $6.00 - 6.10 from $6.00 - 6.20.
    | Jul. 24, 2014, 1:04 PM | Comment!
  • Jul. 24, 2014, 7:37 AM
    • Zimmer Holdings (NYSE:ZMH): Q2 EPS of $1.49 beats by $0.01.
    • Revenue of $1.18B (+0.9% Y/Y) misses by $30M.
    • Press Release
    | Jul. 24, 2014, 7:37 AM | Comment!
  • Apr. 24, 2014, 7:20 AM
    • Zimmer Holdings (ZMH): Q1 EPS of $1.50 beats by $0.03.
    • Revenue of $1.16B (+1.8% Y/Y) misses by $20M.
    • Press Release
    | Apr. 24, 2014, 7:20 AM | Comment!
  • Jan. 30, 2014, 7:32 AM
    • Zimmer Holdings, Inc. (ZMH): FQ1 EPS of $1.66 beats by $0.04.
    • Revenue of $1.24B (+5.1% Y/Y) beats by $20M.
    • Press Release
    | Jan. 30, 2014, 7:32 AM | Comment!
  • Oct. 24, 2013, 7:23 AM
    • Zimmer Holdings (ZMH): Q3 EPS of $1.25 beats by $0.01.
    • Revenue of $1.07B (+4.8% Y/Y) beats by $0.01B. (PR)
    | Oct. 24, 2013, 7:23 AM | Comment!
  • Jul. 25, 2013, 7:18 AM
    Zimmer Holdings (ZMH): Q2 EPS of $1.43 misses by $0.01. Revenue of $1.17B (+4% Y/Y) beats by $0.02B. (PR)
    | Jul. 25, 2013, 7:18 AM | Comment!
  • Apr. 25, 2013, 7:17 AM
    Zimmer Holdings (ZMH): Q1 EPS of $1.41 beats by $0.01. Revenue of $1.14B (-2% Y/Y) in-line . (PR)
    | Apr. 25, 2013, 7:17 AM | Comment!
Visit Seeking Alpha's
ZBH vs. ETF Alternatives
Company Description
Zimmer Biomet Holdings Incis engaged in designing, manufacturing & marketing orthopaedic reconstructive products; sports medicine, biologics, extremities & trauma products; spine, bone healing, craniomaxillofacial & thoracic products &dental implants.